FDA panel backs more study on dyes and child hyperactivity
An FDA advisory panel voted 8-6 to urge further study of links between food colorings and hyperactivity in children while concluding current evidence does not justify warnings on labels. The panel noted some susceptible children may be affected and diets removing dyes can help certain behavioral issues.
MENTIONED IN THIS ARTICLE
FDA
Washington, D.C
Food and Drug Administration
Center For Science In the Public Interest
Michael Jacobson
Europe
U.S
Jacobson
United States
FDA keeps cheaper version of preterm birth drug available
The FDA said providers can continue to make a low cost version of Makena for individual patients despite the high price. KV Pharmaceuticals pledged access remains a priority and will announce actions this week. Doctors welcomed the drug but criticized the $1,500 per dose price.
MENTIONED IN THIS ARTICLE
FDA
Atlanta
Food and Drug Administration
KV Pharmaceutical Co
Death rate for lung cancer among women declines
Washington report shows the first sign that women’s lung cancer deaths are decreasing, dipping just under 1 percent annually. The trend follows decades of higher rates and marks a potential turning point in the smoking driven epidemic.
MENTIONED IN THIS ARTICLE
Washington, D.C
U.S. Men
Elizabeth Ward
American Cancer Society
Journal of the National Cancer Instinite
Also Mentioned on This Page
Wetter Construction Co
Tuc
Hilti
el Enhiad
WitterConstruction.com
Nick Witter
The
Aiken Standard
Space
AikenStandard
Kathy Iboyesie
Fifer
Siuc Intreae
P.O
Eastgate Drive
Aiken
Publix
Medical Directory